It has been further demonstrated that NF-κB antagonizes the transcriptional activity of Nrf2 [32], suggesting that in a pro-inflammatory state, typical of diabetes and obesity, NF-κB activation impairs Glo1 expression by inhibiting Nrf2 action. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.